Ciro Dantas Soares

Dr. Ciro Dantas Soares

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 September 2016 in Lasers in Medical Science
Verified
Journal Article
Closed access
PDF file
MMMelyssa Lima De Medeiros
Melyssa Lima De Medeiros
IAIRAMI ARAÚJO-FILHO
IRAMI ARAÚJO-FILHO
ESEfigênia Maria Nogueira Da Silva
Efigênia Maria Nogueira Da Silva
WQWennye Scarlat De Sousa Queiroz
Wennye Scarlat De Sousa Queiroz
CSCiro Dantas Soares
Ciro Dantas Soares
MMMaria Aparecida Medeiros Maciel
Maria Aparecida Medeiros Maciel

31 May 2017 in Lasers in Medical Science
Verified
Journal Article
Closed access
PDF file
PMPatrícia Froes Meyer
Patrícia Froes Meyer
POPatrícia de Oliveira
Patrícia de Oliveira
FSFlávia K B A Silva
Flávia K B A Silva
ACAna C S da Costa
Ana C S da Costa
CPCaline R A Pereira
Caline R A Pereira
CSCiro Dantas Soares
Ciro Dantas Soares

4 March 2019 in Growth Factors
Verified
Journal Article
Closed access
CSCiro Dantas Soares
Ciro Dantas Soares
TMThayná M. L. Morais
Thayná M. L. Morais
RARoberta M. F. G. Araújo
Roberta M. F. G. Araújo
PMPatrícia F. Meyer
Patrícia F. Meyer
EOEric A. F. Oliveira
Eric A. F. Oliveira
JJJacks Jorge-Junior
Jacks Jorge-Junior
Fibroblast growth factor 2 (FGF2) regulates the wound repair process and it is secreted by inflammatory and endothelial cells, and by myofibroblasts. This study aimed to establish the expression patterns of FGF2 and myofibroblastic differentiation during wound healing in rats treated with subcutaneous ozone injection. We created full-thickness excisional wounds in rats, and the healing process was analyzed through morphometric analyses and digital quantification of immunoreactivity of smooth muscle actin and FGF2. Ozone therapy-treated wounds presented granulation tissue with a reduced number of inflammatory cells and greater dermal cellularity, and intense collagen deposition. FGF2 immunoreactivity, microvessel density, and amount of myofibroblasts were significantly higher in treated wounds compared to controls. In conclusion, it was demonstrated that subcutaneous injections of ozone accelerate and ameliorate wound repairing process. Moreover, injectable ozone therapy’s action mechanism may be associated with FGF2 overexpression.

6 June 2018 in British Journal of Cancer
Verified
Journal Article
Open access
PDF file
CRCésar Rivera
César Rivera
FZFlávia S Zandonadi
Flávia S Zandonadi
CSCeleste Sánchez-Romero
Celeste Sánchez-Romero
CSCiro Dantas Soares
Ciro Dantas Soares
DGDaniela Campos Granato
Daniela Campos Granato
ALAdriana Franco Paes Leme
Adriana Franco Paes Leme
Background The extracellular matrix modulates the hallmarks of cancer. Here we examined the role of agrin—a member of this matrix—in progression of oral squamous cell carcinoma (OSCC). Methods We evaluated the immunohistochemical expression of agrin in OSCC and dysplasias. Benign lesions were used as control. In subsequent experiments, we investigated whether the silencing of agrin interferes with tumour expansion both in vitro as well as in vivo. To gain insights into the role of agrin, we identified its protein network (interactome) using mass spectrometry-based proteomics and bioinformatics. Finally, we evaluated the clinical relevance of agrin interactome. Results Agrin was elevated in malignant and premalignant lesions. Further, we show that agrin silencing interferes with cancer cell motility, proliferation, invasion, colony and tumour spheroid formation, and it also reduces the phosphorylation of FAK, ERK and cyclin D1 proteins in OSCC cells. In orthotopic model, agrin silencing reduces tumour aggressiveness, like vascular and neural invasion. From a clinical perspective, agrin contextual hubs predict a poor clinical prognosis related with overall survival. Conclusions Altogether, our results demonstrate that agrin is a histological marker for the progression of oral cancer and is a strong therapeutic target candidate for both premalignant and OSCC lesions.

6 June 2021 in Journal of Oral Pathology & Medicine
Verified
Journal Article
Closed access
PDF file
JAJosé Alcides Almeida de Arruda
José Alcides Almeida de Arruda
LSLauren Frenzel Schuch
Lauren Frenzel Schuch
NNNicolau Conte Neto
Nicolau Conte Neto
LSLucas Lacerda de Souza
Lucas Lacerda de Souza
CRCarla Isabelly Rodrigues‐Fernandes
Carla Isabelly Rodrigues‐Fernandes
RMRicardo Alves de Mesquita
Ricardo Alves de Mesquita

1 May 2020 in International Journal of Oral and Maxillofacial Surgery
Verified
Journal Article
Closed access
FPF.S.C. Pontes
F.S.C. Pontes
LSL.L. de Souza
L.L. de Souza
MAM.C. de Abreu
M.C. de Abreu
LFL.A. Fernandes
L.A. Fernandes
ARA.L.M. Rodrigues
A.L.M. Rodrigues
HPH.A.R. Pontes
H.A.R. Pontes